On Tuesday, Following Stocks were among the “Top 100 Gainers” of U.S. Stock Market: Hemispherx BioPharma, Inc (NYSEMKT:HEB), XOMA Corp (NASDAQ:XOMA), Arena Pharmaceuticals, Inc (NASDAQ:ARNA), Republic Airways Holdings Inc (NASDAQ:RJET)
Hemispherx BioPharma, Inc (NYSEMKT:HEB)’s shares picked up 5.45%, and closed at $0.240. The stock has price to sale ratio of 261.44, however, price to book ratio is 1.71. With recent incline, the year-to-date (YTD) performance reflected a -4.00% decline below last year. During the past month the stocks lose -4.00%, bringing three-month performance to -4.00% and six-month performance to -22.58%. The mean recommendation of analysts for this stock is 2.00. (where 1=Buy, 5=Sale).
Hemispherx Biopharma, Inc., a specialty pharmaceutical company, is engaged in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders in the United States. The company products comprise Ampligen, an experimental drug, which is under clinical development for the treatment of chronic fatigue syndrome, Hepatitis B, HIV, renal cell carcinoma, and malignant melanoma. Its products also comprise Alferon N Injection, an injectable formulation of natural alpha interferon for the treatment of certain categories of genital warts; and Alferon LDO, a low-dose oral liquid formulation of natural alpha interferon for the treatment of influenza, seasonal influenza, and other emerging viruses.
XOMA Corp (NASDAQ:XOMA), raised 5.38%, and closed at $3.92. The company holds the market capitalization of 432.21M. For the last twelve months, the stock was able to keep return on equity at 733.00%, while return on assets at -42.80%, in response to its return on investment at -211.90%. Its 20-day moving average gained 3.91%, above 50-day moving average of 7.88%, below 200-day moving average of -5.50% from the latest market price of $ 3.92. The mean recommendation of analysts for this stock is 1.80.(where 1=Buy, 5=Sale).
XOMA Corporation discovers and develops antibody-based therapeutics in the United States, Europe, and the Asia Pacific. Its proprietary products comprise gevokizumab, a humanized allosteric-modulating monoclonal antibody that binds to the inflammatory cytokine interleukin-1 beta, which is in Phase III studies for non-infectious uveitis, Behet’s uveitis, pyoderma gangrenosum, active non-infectious anterior scleritis, cardiovascular disease, Schnitzler syndrome, and other diseases, in addition to diseases under the neutrophilic dermatoses designation; and various proof-of-concept studies, counting polymyositis/dermatomyositis, Schnitzler syndrome, and giant cell arteritis.
Arena Pharmaceuticals, Inc (NASDAQ:ARNA), enhanced 5.27%, and closed at $4.99. The stock has the beta value of -0.55, and its volatility for the week is 5.58%, while for the month it is 6.20%. The company has the market capitalization of $366.21M. The company holds the book value per share of 0.21, whereas cash per share is 0.68. Price to book ratio remained 23.76, while price to sale ratio is 32.56. Analysts mean recommendation for the stock is said to be 2.70 (where 1=Buy, 5=sale).
Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight administration in adults. Its products under development comprise APD811, an agonist of the prostacyclin receptor, which has accomplished single- and multiple-ascending dose Phase I trials for the treatment of pulmonary arterial hypertension; and temanogrel, an inverse agonist of the serotonin 2A receptor for the treatment of thrombotic diseases, which has accomplished single- and multiple-ascending dose Phase I trials.
Republic Airways Holdings Inc (NASDAQ:RJET), rose 5.22%, and closed at $14.52. The company has the market capitalization of $691.89M. The beta value of the stock is 0.97. On the other hand the stock’s volatility for the week is 3.96%, and for the month is 4.34%. The stock’s price to book ratio is 1.17, however price to sale ratio is 0.53. Analyst’s mean recommendation regarding this stock is 2.00. (where 1=Buy, 5=Sale).
Republic Airways Holdings Inc., through its subsidiaries, provides planned passenger services. The company offers planned passenger service on about 1,229 flights daily to about 101 cities in the U.S. and Canada. It provides fixed-fee regional airline services under United Express, Delta Connection, or US Airways Express/American Eagle. As of December 31, 2014, the company operated a combined fleet of about 244 aircraft. The company was founded in 1996 and is headquartered in Indianapolis, Indiana.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The data demonstrated in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
